This excerpt taken from the ZGEN 10-Q filed Aug 1, 2007.
5.1.3 Responsibilities of JSC
The JSC shall have responsibility for overseeing the global Development of Collaboration Products, including specifically:
(a) coordinating a global strategy for the Development of Collaboration Products, and overseeing the implementation of such strategy worldwide;
(b) reviewing the Global Development Plan prepared by the JDC and approving the Joint Activities (with amendment as appropriate) together with the annual budget for Development Expenses associated with the Joint Activities as set forth in the Global Development Plan;
(c) coordinating the exchange of Bayer Technology and ZGEN Technology relating to Collaboration Products pursuant to this Agreement;
(d) assigning manufacturing responsibility to a Party with respect to any Collaboration Product;
(e) subject to Section 13.1, approving a strategy with respect to publishing and presenting the results of all Clinical Trials;
(f) reviewing and approving Target Labeling proposed by the JDC;
(g) resolving disputes of the JDC and any other subcommittees established by the JSC; and
(h) performing such other functions as are set forth herein or as the Parties may mutually agree upon in writing, including functions relating to the Initial Licensed Products.